An Approach for the Identification of Targets Specific to Bone Metastasis Using Cancer Genes Interactome and Gene Ontology Analysis

Metastasis is one of the most enigmatic aspects of cancer pathogenesis and is a major cause of cancer-associated mortality. Secondary bone cancer (SBC) is a complex disease caused by metastasis of tumor cells from their primary site and is characterized by intricate interplay of molecular interactions. Identification of targets for multifactorial diseases such as SBC, the most frequent complication of breast and prostate cancers, is a challenge. Towards achieving our aim of identification of targets specific to SBC, we constructed a ‘Cancer Genes Network’, a representative protein interactome of cancer genes. Using graph theoretical methods, we obtained a set of key genes that are relevant for generic mechanisms of cancers and have a role in biological essentiality. We also compiled a curated dataset of 391 SBC genes from published literature which serves as a basis of ontological correlates of secondary bone cancer. Building on these results, we implement a strategy based on generic cancer genes, SBC genes and gene ontology enrichment method, to obtain a set of targets that are specific to bone metastasis. Through this study, we present an approach for probing one of the major complications in cancers, namely, metastasis. The results on genes that play generic roles in cancer phenotype, obtained by network analysis of ‘Cancer Genes Network’, have broader implications in understanding the role of molecular regulators in mechanisms of cancers. Specifically, our study provides a set of potential targets that are of ontological and regulatory relevance to secondary bone cancer.

[1]  M. DePamphilis,et al.  HUMAN DISEASE , 1957, The Ulster Medical Journal.

[2]  Leonard M. Freeman,et al.  A set of measures of centrality based upon betweenness , 1977 .

[3]  A. Wyllie,et al.  Cell death: the significance of apoptosis. , 1980, International review of cytology.

[4]  L. Liotta,et al.  Role of laminin in the attachment and metastasis of murine tumor cells. , 1982, Cancer research.

[5]  W. Lee,et al.  Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[6]  L. Liotta,et al.  Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation , 1991, Cell.

[7]  K. Pavelić,et al.  c-fms is present in primary tumours as well as in their metastases in bone marrow. , 1992, International journal of experimental pathology.

[8]  M. Gerretsen,et al.  A phase III randomised trial of cisplatinum, methotrextate, cisplatinum + methotrexate and cisplatinum + 5-FU in end stage squamous carcinoma of the head and neck. Liverpool Head and Neck Oncology Group. , 1990, British Journal of Cancer.

[9]  C. Harris,et al.  p53 tumor suppressor gene: from the basic research laboratory to the clinic--an abridged historical perspective. , 1996, Carcinogenesis.

[10]  R. Coleman Skeletal complications of malignancy , 1997, Cancer.

[11]  A. Levine p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[12]  F. Rauch,et al.  Markers of bone and collagen metabolism-problems and perspectives in paediatrics. , 1997, Hormone research.

[13]  Duncan J. Watts,et al.  Collective dynamics of ‘small-world’ networks , 1998, Nature.

[14]  G. Adler,et al.  Integrin alpha6beta1 role in metastatic behavior of human pancreatic carcinoma cells. , 1999, International journal of cancer.

[15]  S. Schwartz,et al.  Prognostic value of immunohistochemical expression of the c‐erbB‐2 oncoprotein in metastasic prostate cancer , 1999, International journal of cancer.

[16]  S. Kern,et al.  G1 cell cycle arrest and apoptosis induction by nuclear Smad4/Dpc4: phenotypes reversed by a tumorigenic mutation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[17]  L. Lau,et al.  The CCN family of angiogenic regulators: the integrin connection. , 1999, Experimental cell research.

[18]  P. Carmeliet,et al.  Angiogenesis in cancer and other diseases , 2000, Nature.

[19]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[20]  H. Ariga,et al.  Tumour invasion and metastasis are promoted in mice deficient in tenascin‐X , 2001, Genes to cells : devoted to molecular & cellular mechanisms.

[21]  R. Vessella,et al.  Placental bone morphogenetic protein (PLAB) gene expression in normal, pre‐malignant and malignant human prostate: Relation to tumor development and progression , 2001, International journal of cancer.

[22]  M. Moore,et al.  The role of chemoattraction in cancer metastases. , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.

[23]  A. Barabasi,et al.  Lethality and centrality in protein networks , 2001, Nature.

[24]  J. Blake,et al.  Creating the Gene Ontology Resource : Design and Implementation The Gene Ontology Consortium 2 , 2001 .

[25]  R. Kitazawa,et al.  Epigenetic Regulation of Human Bone Morphogenetic Protein 6 Gene Expression in Prostate Cancer , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[26]  U. Brandes A faster algorithm for betweenness centrality , 2001 .

[27]  S. Plymate,et al.  Regulation of proliferation of prostate epithelial cells by 1,25-dihydroxyvitamin D3 is accompanied by an increase in insulin-like growth factor binding protein-3. , 2001, The Journal of endocrinology.

[28]  Albert-László Barabási,et al.  Statistical mechanics of complex networks , 2001, ArXiv.

[29]  F. Rösel,et al.  Down regulation of the tumor suppressor gene maspin in breast carcinoma is associated with a higher risk of distant metastasis. , 2001, Clinical biochemistry.

[30]  K. Sneppen,et al.  Specificity and Stability in Topology of Protein Networks , 2002, Science.

[31]  A. Montag,et al.  Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic disease. , 2002, Cancer research.

[32]  W. Hahn,et al.  Modelling the molecular circuitry of cancer , 2002, Nature Reviews Cancer.

[33]  S H Strogatz,et al.  Random graph models of social networks , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Evan T Keller,et al.  Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. , 2002, Cancer research.

[35]  G. Mundy Metastasis: Metastasis to bone: causes, consequences and therapeutic opportunities , 2002, Nature Reviews Cancer.

[36]  R. Anderson,et al.  Genes involved in breast cancer metastasis to bone , 2002, Cellular and Molecular Life Sciences CMLS.

[37]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[38]  L. Chung,et al.  New targets for therapy in prostate cancer: modulation of stromal-epithelial interactions. , 2003, Urology.

[39]  H. Kim,et al.  Platelet-derived growth factor signaling and human cancer. , 2003, Journal of biochemistry and molecular biology.

[40]  C. Cordon-Cardo,et al.  A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.

[41]  K. Miura,et al.  The Drg-1 gene suppresses tumor metastasis in prostate cancer. , 2003, Cancer research.

[42]  C. Logothetis,et al.  Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[43]  Hanno Steen,et al.  Development of human protein reference database as an initial platform for approaching systems biology in humans. , 2003, Genome research.

[44]  S. Hirohashi,et al.  Cell adhesion system and human cancer morphogenesis , 2003, Cancer science.

[45]  Jun Luo,et al.  Trefoil factor 3 overexpression in prostatic carcinoma: Prognostic importance using tissue microarrays , 2004, The Prostate.

[46]  R. Behringer,et al.  Bone Morphogenetic Protein Type IA Receptor Signaling Regulates Postnatal Osteoblast Function and Bone Remodeling* , 2004, Journal of Biological Chemistry.

[47]  Pamela A. Silver,et al.  Nuclear transport and cancer: from mechanism to intervention , 2004, Nature Reviews Cancer.

[48]  A. Chambers,et al.  Role of osteopontin in tumour progression , 2004, British Journal of Cancer.

[49]  P. Troncoso,et al.  Up‐regulation of MDA‐BF‐1, a secreted isoform of ErbB3, in metastatic prostate cancer cells and activated osteoblasts in bone marrow , 2004, The Journal of pathology.

[50]  K. Kinzler,et al.  Cancer genes and the pathways they control , 2004, Nature Medicine.

[51]  Kenneth M. Yamada,et al.  Fibronectin and integrins in invasion and metastasis , 1995, Cancer and Metastasis Reviews.

[52]  Jer-Tsong Hsieh,et al.  The role of cell adhesion molecule in cancer progression and its application in cancer therapy. , 2004, Acta biochimica Polonica.

[53]  A. Barabasi,et al.  Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.

[54]  Cynthia L. Smith,et al.  The Mammalian Phenotype Ontology as a tool for annotating, analyzing and comparing phenotypic information , 2004, Genome Biology.

[55]  R. Kannagi,et al.  Carbohydrate‐mediated cell adhesion in cancer metastasis and angiogenesis , 2004, Cancer science.

[56]  Robin L. Anderson,et al.  Caveolin-1 inhibits breast cancer growth and metastasis , 2004, Oncogene.

[57]  V. Vasioukhin Hepsin Paradox Reveals Unexpected Complexity of Metastatic Process , 2004, Cell cycle.

[58]  Kerstin Knerr,et al.  Bone metastasis: Osteoblasts affect growth and adhesion regulons in prostate tumor cells and provoke osteomimicry , 2004, International journal of cancer.

[59]  Sergey N. Dorogovtsev,et al.  The shortest path to complex networks , 2004, ArXiv.

[60]  M. Ittmann,et al.  The role of fibroblast growth factors and their receptors in prostate cancer. , 2004, Endocrine-related cancer.

[61]  J. Peterse,et al.  Breast cancer metastasis: markers and models , 2005, Nature Reviews Cancer.

[62]  T. Guise,et al.  Breast Cancer Metastasis to Bone: Mechanisms of Osteolysis and Implications for Therapy , 2005, Journal of Mammary Gland Biology and Neoplasia.

[63]  S. Raguz,et al.  Expression of RPIP9 (Rap2 interacting protein 9) is activated in breast carcinoma and correlates with a poor prognosis , 2005, International journal of cancer.

[64]  W. Gerald,et al.  Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. , 2005, The Journal of clinical investigation.

[65]  D. Ingber,et al.  High-Betweenness Proteins in the Yeast Protein Interaction Network , 2005, Journal of biomedicine & biotechnology.

[66]  Hwai-Shi Wang,et al.  CD44 cross-linking induces integrin-mediated adhesion and transendothelial migration in breast cancer cell line by up-regulation of LFA-1 (alpha L beta2) and VLA-4 (alpha4beta1). , 2005, Experimental cell research.

[67]  H. Lehrach,et al.  A Human Protein-Protein Interaction Network: A Resource for Annotating the Proteome , 2005, Cell.

[68]  K. Kelly,et al.  Mechanisms of cancer metastasis to the bone , 2005, Cell Research.

[69]  Hwai-Shi Wang,et al.  CD44 Cross-linking induces integrin-mediated adhesion and transendothelial migration in breast cancer cell line by up-regulation of LFA-1 (αLβ2) and VLA-4 (α4β1) , 2005 .

[70]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[71]  K. Eppert,et al.  von Willebrand factor expression in osteosarcoma metastasis , 2005, Modern Pathology.

[72]  P. Delmas,et al.  The role of collagen in bone strength , 2005, Osteoporosis International.

[73]  Anna Frolov,et al.  Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression. , 2005, Cancer research.

[74]  Paul A. Bates,et al.  Global topological features of cancer proteins in the human interactome , 2006, Bioinform..

[75]  S. M. Sims,et al.  Regulation of cancer cell migration and bone metastasis by RANKL , 2006, Nature.

[76]  M. Oursler,et al.  Breast cancer bone metastasis and current small therapeutics , 2007, Cancer and Metastasis Reviews.

[77]  Wei Wei,et al.  Metastatic patterns in adenocarcinoma , 2006, Cancer.

[78]  G. Kundu,et al.  Osteopontin: role in cell signaling and cancer progression. , 2006, Trends in cell biology.

[79]  A. Giuliano,et al.  Epigenetic Analysis of Body Fluids and Tumor Tissues , 2006, Annals of the New York Academy of Sciences.

[80]  Kumaran Kandasamy,et al.  An evaluation of human protein-protein interaction data in the public domain , 2006, BMC Bioinformatics.

[81]  Soichiro Ibaragi,et al.  Pathogenic Role of Connective Tissue Growth Factor (CTGF/CCN2) in Osteolytic Metastasis of Breast Cancer , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[82]  George W. Yip,et al.  Therapeutic value of glycosaminoglycans in cancer , 2006, Molecular Cancer Therapeutics.

[83]  Mike Tyers,et al.  Evolutionary and Physiological Importance of Hub Proteins , 2006, PLoS Comput. Biol..

[84]  A. Potti,et al.  Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation , 2006, Cancer.

[85]  V. Castronovo,et al.  Transcriptome analysis reveals an osteoblast-like phenotype for human osteotropic breast cancer cells , 2006, Breast Cancer Research and Treatment.

[86]  Yi Zhang,et al.  Genes associated with breast cancer metastatic to bone. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[87]  Chris Sander,et al.  CancerGenes: a gene selection resource for cancer genome projects , 2006, Nucleic Acids Res..

[88]  J. Lieberman,et al.  Tumor metastasis to bone , 2007, Arthritis research & therapy.

[89]  J. Collins,et al.  A network biology approach to prostate cancer , 2007, Molecular systems biology.

[90]  T. Yoneda,et al.  Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer. , 2007, Cancer research.

[91]  Takuya Akashi,et al.  Chemokine receptors in cancer metastasis and cancer cell‐derived chemokines in host immune response , 2007, Cancer science.

[92]  King-Jen Chang,et al.  CTGF enhances the motility of breast cancer cells via an integrin-alphavbeta3-ERK1/2-dependent S100A4-upregulated pathway. , 2007, Journal of cell science.

[93]  Therese Sørlie,et al.  Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer , 2007, Molecular oncology.

[94]  A. Barabasi,et al.  The human disease network , 2007, Proceedings of the National Academy of Sciences.

[95]  A. Barabasi,et al.  Drug—target network , 2007, Nature Biotechnology.

[96]  Frank Emmert-Streib,et al.  The Chronic Fatigue Syndrome: A Comparative Pathway Analysis , 2007, J. Comput. Biol..

[97]  C. Schem,et al.  Increased COX2 expression enhances tumor-induced osteoclastic lesions in breast cancer bone metastasis , 2008, Clinical & Experimental Metastasis.

[98]  Mark Gerstein,et al.  The Importance of Bottlenecks in Protein Networks: Correlation with Gene Essentiality and Expression Dynamics , 2007, PLoS Comput. Biol..

[99]  T. Ideker,et al.  Network-based classification of breast cancer metastasis , 2007, Molecular systems biology.

[100]  Elliot P. Douglas,et al.  Bone structure and formation: A new perspective , 2007 .

[101]  C. Logothetis,et al.  Cadherin-11 Promotes the Metastasis of Prostate Cancer Cells to Bone , 2008, Molecular Cancer Research.

[102]  K. Dolinski,et al.  Use and misuse of the gene ontology annotations , 2008, Nature Reviews Genetics.

[103]  T. Yoneda,et al.  Breast cancer‐derived Dickkopf1 inhibits osteoblast differentiation and osteoprotegerin expression: Implication for breast cancer osteolytic bone metastases , 2008, International journal of cancer.

[104]  Brian Bierie,et al.  Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment. , 2008, Cancer research.

[105]  A. Bjartell,et al.  FGF‐8 is involved in bone metastasis of prostate cancer , 2008, International journal of cancer.

[106]  Israel Steinfeld,et al.  BMC Bioinformatics BioMed Central , 2008 .

[107]  T. Plesner,et al.  A physical mechanism for coupling bone resorption and formation in adult human bone. , 2008, The American journal of pathology.

[108]  P. Casey,et al.  Activation of Rap1 promotes prostate cancer metastasis. , 2009, Cancer research.

[109]  Larry Norton,et al.  Latent bone metastasis in breast cancer tied to Src-dependent survival signals. , 2009, Cancer cell.

[110]  Mauno Vihinen,et al.  Identification of candidate disease genes by integrating Gene Ontologies and protein-interaction networks: case study of primary immunodeficiencies , 2008, Nucleic acids research.

[111]  J. Ramser,et al.  Identification of brain- and bone-specific breast cancer metastasis genes. , 2009, Cancer letters.

[112]  Mark E. J. Newman,et al.  Power-Law Distributions in Empirical Data , 2007, SIAM Rev..

[113]  N. Selvamurugan,et al.  Transforming growth factor‐β1 regulation of ATF‐3 and identification of ATF‐3 target genes in breast cancer cells , 2009, Journal of cellular biochemistry.

[114]  G. Cao,et al.  Identification of novel hub genes associated with liver metastasis of gastric cancer , 2009, International journal of cancer.

[115]  M. Hung,et al.  Regulation of Breast Cancer Metastasis by Atypical Chemokine Receptors , 2009, Clinical Cancer Research.

[116]  Qiongqing Wang,et al.  ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis. , 2009, Genes & development.

[117]  R. Vessella,et al.  Protease‐activated receptor‐1 is upregulated in reactive stroma of primary prostate cancer and bone metastasis , 2009, The Prostate.

[118]  T. Guise Breaking down bone: new insight into site-specific mechanisms of breast cancer osteolysis mediated by metalloproteinases. , 2009, Genes & development.

[119]  R. Vessella,et al.  Dasatinib inhibits the growth of prostate cancer in bone and provides additional protection from osteolysis , 2009, British Journal of Cancer.

[120]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[121]  A. Kazlauskas,et al.  The alpha-receptor for platelet-derived growth factor confers bone-metastatic potential to prostate cancer cells by ligand- and dimerization-independent mechanisms. , 2010, Cancer research.

[122]  Xin Lu,et al.  In vivo dynamics and distinct functions of hypoxia in primary tumor growth and organotropic metastasis of breast cancer. , 2010, Cancer research.

[123]  A. Barabasi,et al.  Network medicine : a network-based approach to human disease , 2010 .

[124]  Pekka Kohonen,et al.  Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis , 2010, Breast Cancer Research and Treatment.

[125]  I. Fidler,et al.  AACR centennial series: the biology of cancer metastasis: historical perspective. , 2010, Cancer research.

[126]  C. Sander,et al.  Automated Network Analysis Identifies Core Pathways in Glioblastoma , 2010, PloS one.

[127]  R. Dhir,et al.  Plasma fibronectin promotes lung metastasis by contributions to fibrin clots and tumor cell invasion. , 2010, Cancer research.

[128]  E. Scarpi,et al.  The Role of CXCR4 in the Prediction of Bone Metastases from Breast Cancer: A Pilot Study , 2011, Oncology.

[129]  Peilin Jia,et al.  A comprehensive network and pathway analysis of candidate genes in major depressive disorder , 2011, BMC Systems Biology.

[130]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[131]  Chiara Secondini,et al.  The Role of the BMP Signaling Antagonist Noggin in the Development of Prostate Cancer Osteolytic Bone Metastasis , 2011, PloS one.

[132]  K. Hemminki,et al.  Systematic enrichment analysis of gene expression profiling studies identifies consensus pathways implicated in colorectal cancer development , 2011, Journal of carcinogenesis.

[133]  Judith A. Blake,et al.  The Mouse Genome Database (MGD): premier model organism resource for mammalian genomics and genetics , 2010, Nucleic Acids Res..

[134]  R. Weinberg,et al.  A Perspective on Cancer Cell Metastasis , 2011, Science.

[135]  R. Tsien,et al.  Specificity and Stability in Topology of Protein Networks , 2022 .